These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21342068)

  • 21. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008.
    Patel P; Mackellar D; Simmons P; Uniyal A; Gallagher K; Bennett B; Sullivan TJ; Kowalski A; Parker MM; LaLota M; Kerndt P; Sullivan PS;
    Arch Intern Med; 2010 Jan; 170(1):66-74. PubMed ID: 20065201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Laboratory diagnosis in HIV infection].
    Matter L
    Schweiz Med Wochenschr; 1991 Aug; 121(34):1183-6. PubMed ID: 1925446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uganda's same-day testing works well for everyone.
    AIDS Alert; 1997 Dec; 12(12 Suppl):3-4. PubMed ID: 11364839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use in Mozambique of WHO diagnostic strategies in HIV infection].
    Louis FJ; Perret JL; Morillon M; Pina JJ; Lesens O; de Vaucouleurs AB; Martet G
    Sante; 1999; 9(2):111-4. PubMed ID: 10377498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bayesian inference on prevalence using a missing-data approach with simulation-based techniques: applications to HIV screening.
    Mendoza-Blanco JR; Tu XM; Iyengar S
    Stat Med; 1996 Oct; 15(20):2161-76. PubMed ID: 8910961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One or two enzyme-linked immunosorbent assay tests on the first serum sample for initial diagnosis of HIV-1 infection?
    Costagliola D; Damond F; Palmer P; Rouzioux C; Brun-Vezinet F
    AIDS; 2008 Oct; 22(15):2042-4. PubMed ID: 18784468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Calypte AWARE HIV-1/2 OMT antibody test as a screening test in an Indian setting.
    Ingole NA; Mehta PR; Bande RN; Paranjpe SM; Wanjare SW
    Indian J Med Microbiol; 2010; 28(4):295-8. PubMed ID: 20966557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of rapid HIV testing strategies in under equipped laboratories in the Central African Republic.
    Ménard D; Maïro A; Mandeng MJ; Doyemet P; Koyazegbe Td; Rochigneux C; Talarmin A
    J Virol Methods; 2005 Jun; 126(1-2):75-80. PubMed ID: 15847921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calypte AWARE HIV-1/2 OMT antibody test using oral fluid: special challenges of rapid HIV testing in the developing world.
    Gottfried TD; Mink RW; Phanuphak P
    Expert Rev Mol Diagn; 2006 Mar; 6(2):139-44. PubMed ID: 16512774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV infection: point-of-care testing.
    Donovan BJ; Rublein JC; Leone PA; Pilcher CD
    Ann Pharmacother; 2004 Apr; 38(4):670-6. PubMed ID: 14990775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV testing and prevention issues for women attending termination assessment clinics.
    Bergenstrom A; Sherr L
    Br J Fam Plann; 1999 Apr; 25(1):3-8. PubMed ID: 10228241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testing. Veterans study: rapid tests effective tool in HIV/AIDS war.
    AIDS Policy Law; 2006 Sep; 21(17):5. PubMed ID: 17022117
    [No Abstract]   [Full Text] [Related]  

  • 33. Routine, rapid HIV testing.
    Rotheram-Borus MJ; Leibowitz AA; Etzel MA
    AIDS Educ Prev; 2006 Jun; 18(3):273-80. PubMed ID: 16774468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factor analysis and serological diagnosis of HIV-1/HIV-2 infection in a Brazilian blood donor population: validation of the World Health Organization strategy for HIV testing.
    Carvalho MB; Hamerschlak N; Vaz RS; Ferreira OC
    AIDS; 1996 Sep; 10(10):1135-40. PubMed ID: 8874631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies.
    Delaney KP; Branson BM; Uniyal A; Kerndt PR; Keenan PA; Jafa K; Gardner AD; Jamieson DJ; Bulterys M
    AIDS; 2006 Aug; 20(12):1655-60. PubMed ID: 16868447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of indirect immunofluorescence as a supplementary test for the diagnosis of HIV-1 infection].
    Ceballos A; Devito C; Pampuro S; Gómez Carrillo M; Libonatti O; Martínez Peralta L
    Rev Argent Microbiol; 1998; 30(2):59-63. PubMed ID: 9744031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of rapid tests and algorithms for HIV screening in Abidjan, Ivory Coast.
    Loukou YG; Cabran MA; Yessé ZN; Adouko BM; Lathro SJ; Agbessi-Kouassi KB
    J Int Assoc Provid AIDS Care; 2014; 13(1):35-9. PubMed ID: 23803564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries.
    McDougal JS; Pilcher CD; Parekh BS; Gershy-Damet G; Branson BM; Marsh K; Wiktor SZ
    AIDS; 2005 May; 19 Suppl 2():S25-30. PubMed ID: 15930838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variation in specificity of HIV rapid diagnostic tests over place and time: an analysis of discordancy data using a Bayesian approach.
    Klarkowski D; Glass K; O'Brien D; Lokuge K; Piriou E; Shanks L
    PLoS One; 2013; 8(11):e81656. PubMed ID: 24282615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Issues in human immunodeficiency virus (HIV) screening programs.
    Tu XM; Litvak E; Pagano M
    Am J Epidemiol; 1992 Jul; 136(2):244-55. PubMed ID: 1415146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.